FDA Floats OTC Monograph Overhaul To Be “More Agile”
The agency will conduct a public hearing on March 25 and 26 for comments about improving the OTC monograph process, which currently faces “significant challenges.”
The agency will conduct a public hearing on March 25 and 26 for comments about improving the OTC monograph process, which currently faces “significant challenges.”